MLLT3 and leukemia: In addition, co-expression of the MLL1(2–44) peptide, which is a dominant negative inhibitor of the Menin–MLL1 interaction, inhibited proliferation of MLL1-AF9 transformed leukemia cells with significantly reduced expression of Meis1 [115].